Page last updated: 2024-08-26

lysophosphatidic acid and Heart Disease, Ischemic

lysophosphatidic acid has been researched along with Heart Disease, Ischemic in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Charbeneau, RA; Huang, X; Kaur, K; Neubig, RR; Parra, S; Rorabaugh, BR; Wade, SM	1
Abdel-Latif, A; Heron, PM; Morris, AJ; Smyth, SS	1
Chen, J; Chen, X; Cong, X; Hou, J; Hu, S; Liu, X; Sang, J; Shi, L	1
Tomei, LD; Umansky, SR	1

Reviews

2 review(s) available for lysophosphatidic acid and Heart Disease, Ischemic

Article	Year
Lysophospholipids in coronary artery and chronic ischemic heart disease. Current opinion in lipidology, 2015, Volume: 26, Issue:5 Topics: Animals; Atherosclerosis; Coronary Artery Disease; Humans; Lysophospholipids; Myocardial Ischemia; Signal Transduction; Sphingosine	2015
Apoptosis in the myocardium: much is still expected. Expert opinion on therapeutic targets, 2003, Volume: 7, Issue:1 Topics: Animals; Apoptosis; Biological Evolution; Cardiovascular Agents; Cell Differentiation; Cysteine Proteinase Inhibitors; Drug Design; Endothelial Cells; Humans; Lysophospholipids; Myocardial Ischemia; Myocarditis; Myocardium; Myocytes, Cardiac; Necrosis; Rats; Signal Transduction	2003

Article

Year

Lysophospholipids in coronary artery and chronic ischemic heart disease.

Current opinion in lipidology, 2015, Volume: 26, Issue:5

Topics: Animals; Atherosclerosis; Coronary Artery Disease; Humans; Lysophospholipids; Myocardial Ischemia; Signal Transduction; Sphingosine

2015

Apoptosis in the myocardium: much is still expected.

Expert opinion on therapeutic targets, 2003, Volume: 7, Issue:1

Topics: Animals; Apoptosis; Biological Evolution; Cardiovascular Agents; Cell Differentiation; Cysteine Proteinase Inhibitors; Drug Design; Endothelial Cells; Humans; Lysophospholipids; Myocardial Ischemia; Myocarditis; Myocardium; Myocytes, Cardiac; Necrosis; Rats; Signal Transduction

2003

Other Studies

2 other study(ies) available for lysophosphatidic acid and Heart Disease, Ischemic

Article	Year
Conditional disruption of interactions between Gαi2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury. BMC pharmacology & toxicology, 2014, Jun-05, Volume: 15 Topics: Animals; Cells, Cultured; Cyclic AMP; Fibroblasts; GTP-Binding Protein alpha Subunit, Gi2; Lysophospholipids; Mice; Mice, Transgenic; Mutation; Myocardial Ischemia; Myocardium; RGS Proteins; Tamoxifen	2014
Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo. Stem cells and development, 2009, Volume: 18, Issue:7 Topics: Animals; Apoptosis; Cell Hypoxia; Cell Survival; Cells, Cultured; Female; Lysophospholipids; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Ischemia; Paracrine Communication; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Vascular Endothelial Growth Factor A	2009

Article

Year

Conditional disruption of interactions between Gαi2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury.

BMC pharmacology & toxicology, 2014, Jun-05, Volume: 15

Topics: Animals; Cells, Cultured; Cyclic AMP; Fibroblasts; GTP-Binding Protein alpha Subunit, Gi2; Lysophospholipids; Mice; Mice, Transgenic; Mutation; Myocardial Ischemia; Myocardium; RGS Proteins; Tamoxifen

2014

Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo.

Stem cells and development, 2009, Volume: 18, Issue:7

Topics: Animals; Apoptosis; Cell Hypoxia; Cell Survival; Cells, Cultured; Female; Lysophospholipids; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardial Ischemia; Paracrine Communication; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Vascular Endothelial Growth Factor A

2009